Intra-Uterine Contraceptive Devices Market - Upcoming Scope and Challenges Analysis Report 2018 to 2025: Dominated by Mona Lisa N.V., DKT INTERNATIONAL, OCON Medical Ltd, Pregna International Limited, MedWOW Global, Bayer AG

Databridgemarketresearch.com Adds “Global Intra-Uterine Contraceptive Devices Market Size, Status and Forecast 2025” The objective of the report is to define, describe, and forecast the size on the basis of end user, geography, applications, industry types, and regions.

Global Intra-Uterine Contraceptive Devices Market, According to Data Bridge Market Research new Market report, “By Product Type (Copper IUCD, Hormonal IUCD), By End-User (Hospitals, Gynecology Clinics, Community Healthcare), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast is projected to reach USD 5289.17 million by 2025, at a CAGR of 4.1% during the forecast period of 2018 to 2025.

Get Free Sample Copy of Report at https://databridgemarketresearch.com/request-a-sample/?dbmr=global-intra-uterine-contraceptive-devices-market

Global Intra-Uterine Contraceptive Devices Market

Intrauterine contraceptive device (IUD) is a T-shaped, small-sized, birth control device that is inserted into woman’s uterus to prevent pregnancy. These devices are highly economical, effective, and safe birth control devices. Their major role is that they prevent pregnancy for a long period of time and prevent the chances of ectopic pregnancy. They are considered to be 99.0% effective in preventing pregnancy. There are two types of intrauterine devices copper-releasing intrauterine devices and progesterone-releasing intrauterine devices. Copper-releasing intrauterine device works by releasing copper. This copper enhances the inflammatory reaction in the uterus which prevents fertilization of eggs. Progesterone-releasing intrauterine device works by releasing progestin, which thickens the cervical mucus and creates the barrier to sperms.

In 2016, The U.S. Food and Drug Administration pharms approved Bayer AG’s low dose levonorgestrel-releasing intrauterine system. It marketed in the United States under the brand name KyleenaTM. Kyleena releases the lowest daily dose of the hormone levonorgestrel in an intrauterine system for up to five years. This is very effective protection against pregnancy, using the smallest T-shaped body available today.

Allergan in 2016 launched single-handed Liletta IUD inserter.

Table Of Contents Available For This Market Request For TOC Here at https://databridgemarketresearch.com/toc/?dbmr=global-intra-uterine-contraceptive-devices-market

Segmentation: Global Intra-Uterine Contraceptive Devices Market

The global market for intra-uterine contraceptive devices by the following sub-categories is presented

By Product Type

Copper IUCD
Hormonal IUCD

By End-User

Hospitals
Gynecology Clinics
Community Healthcare

By Geography

North America
South America
Europe
Asia-Pacific
Middle East and Africa

For Customized Reports and Discounts, Mail us @ sopan.gedam@databridgemarketresearch.com

FACTORS DRIVING GROWTH IN THE GLOBAL INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET

The increased rate of unplanned pregnancies:

The rate of unintended pregnancy is increasing year after year, and the government initiatives regarding birth control and use of intra-uterine contraceptive devices in on the rise.

In 2010, at least 36.0% of pregnancies in every United States were unintended. In 2011, nearly half (45.0% or 2.8 million) of the 6.1 million pregnancies in the United States were unintended. In 2011, there were 45 the rate of unintended pregnancies was 45 per 1,000 women in an aged group between 15years –44years. According to a journal published by the lancet global health, 15·6 million abortions (14·1 million–17·3 million) occurred in India in 2015. The rate of abortion was 47 per 1000 women. 3.4 million Abortion occur in health facilities (22.0%). 11.5 million abortion abortions were done through medication (73.0%), 2.2 million abortions were surgical (14.0%).

According to national center for biotechnology information, in 2012 there were 85 million reported pregnancies, out of which 40.0% of all pregnancies were unintended. Of these, 50.0% ended in abortion, 13.0% ended in miscarriage, and 38.0% resulted in an unplanned birth.

Growing awareness of contraceptive:

According to “the hindu” news of 2014, government has joined hands with the Federation of Obstetric and gynaecological Societies of India (FOGSI) and international federation of gynaecology and Obstetrics (FIGO) to train doctors and nurses to make intra-uterine contraceptive devices insertion as part of their routine activities.

According to national center for biotechnology information, in Ethiopia Since 2011, the integrated family health program, implemented by pathfinder international and John Snow Inc., has supported the federal ministry of health to introduce intrauterine devices in more than 800 healthcare centers across 4 regions to improve access to a wider range of methods.

To avoid the unwanted pregnancy, and to offer a better family planning, government of most of the countries are taking an active part in promoting the use of intra-uterine contraceptive devices. These factors are driving this market to achieve a stable platform in future.

Some of the major market players in this market are Bayer AG, Teva Pharmaceutical Industries Ltd, Mona Lisa N.V., DKT INTERNATIONAL, OCON Medical Ltd, Pregna International Limited, MedWOW Global, SMB Corporation of India, Meril Life Sciences Pvt. Ltd, GYNEAS, Melbea Innovations, Meril Life Sciences Pvt. Ltd, Melbea AG, Medicines360, ALLERGAN, Agile therapeutics Inc. among others.

Place Direct Purchase Order of Intra-Uterine Contraceptive Devices Market at https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-intra-uterine-contraceptive-devices-market

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.